The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts

Maternal and Child Health Journal

Volumn 21, Issue 4, 2017, Pages 893-902

  Kotelchuck, Milton ^a   Cheng, Erika R ^b   Belanoff, Candice ^c   Cabral, Howard J ^c   Babakhanlou Chase, Hermik ^d   Derrington, Taletha M ^e   Diop, Hafsatou ^d   Evans, Stephen R ^c   Bernstein, Judith ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^e SRI INTERNATIONAL   (United States)

Author keywords

Linked health data systems; Perinatal health services utilization; Perinatal outcomes; Pregnancy; Substance use disorder; SUD treatment

Indexed keywords

ADULT; COMPLICATION; DRUG DEPENDENCE; FEMALE; HUMAN; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MALE; MASSACHUSETTS; NEWBORN; NEWBORN DISEASE; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADULT; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREVALENCE; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84994753112     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-016-2190-y     Document Type: Article

References (32)

1. Bada, H. S., Das, A., Bauer, C. R., Shanrakan, S., Lester, B., et al. (2002). Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study. Obstetrics and Gynecology, 100, 916–924.
2. Behnke, M., Smith, V. C., Committee on Substance Abuse, Committee on Fetus and Newborn. (2013). Prenatal substance abuse: Short- and long-term effects on the exposed fetus. Pediatrics, 131, e1009–1024.
3. Bernstein, J., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., Derrington, T., et al. (2015). Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts. Drug and Alcohol Dependence, 147, 151–159.
4. Bernstein, J., Bernstein, E., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., et al. (2014). The association of injury with substance abuse disorder among women of reproductive age: An opportunity to address a major contributor to recurrent preventable ED visits? Academic Emergency Medicine, 21, 1459–1468.
5. Boucher, N., Bairam, A., & Beaulac-Baillargeon, L. (2008). A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy. Journal of Clinical Psychopharmacology, 28(3), 334–339.
6. Burns, L., & Mattick, R. P. (2007). Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug and Alcohol Review, 26(5), 487–492.
7. CDC Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States 2000–2014. Accessed 12/22/15 at http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf.
8. Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States. Results from the 2014 National Survey on Drug Use and Health. (HHS Publication No. SMA 15-4927).
9. Conradt, E., Abar, B., Sheinkopf, S., Lester, B., et al. (2014). The role of prenatal substance exposure and early adversity on parasympathetic functioning from 3 to 6 years of age. Developmental Psychobiology, 56, 821–835.
10. Crome, I. B., & Kumar, M. T. (2007). Epidemiology of drug and alcohol use in young women. Seminars in Fetal and Neonatal. Medicine, 12(2), 98–105.
11. Derrington, T., Bernstein, J., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., Diop, H., et al. (2015). Development of a grouping tool to identify women of child-bearing age with probable substance use disorders: the explicit-mention substance abuse need for treatment in women (EMSANT-W) algorithm. Maternal and Child Health Journal, 19(10), 2168–2178.
12. Escobar, G. J., Li, D. K., Armstrong, M. A., Gardner, M. N., Folck, B. F., et al. (2002). Neonatal sepsis workup in infants ≥2000 grams at birth: A population-based study. Pediatrics, 106, 256–263.
13. Fabris, C., Prandi, G., Perathoner, C., & Soldi, A. (1998). Neonatal drug addiction. Panminerva Medica, 40(3), 239–243.
14. Funkhouser, A. W., Butz, A. M., Feng, T. I., McCaul, M. E., & Rosenstein, B. J. (1993). Prenatal care and drug use in pregnant women. Drug and Alcohol Dependence, 33(1), 1–9.
15. Harrison, P. A., & Sidebottom, A. C. (2008). Systematic prenatal screening for psychosocial risks. Journal of Health Care for the Poor and Underserved, 19(1), 258–276.
16. Huestis, M. A., & Choo, R. E. (2002). Drug abuse’s smallest victims: In utero drug exposure. Forensic Science International, 128(1–2), 20–30.
17. Kotelchuck, M. (1994). An evaluation of the kessner adequacy of prenatal care index and a proposed adequacy of prenatal care utilization index. American Journal of Public Health, 84(9), 1414–1420.
18. Lester, B. M., & Lagasse, L. L. (2010). Children of addicted women. Journal of Addictive Disease, 29(2), 259–276.
19. Lester, B. M., Tronick, E. Z., LaGasse, L., Seifer, R., Bauer, C. R., et al. (2002). The maternal lifestyle study: Effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics, 110(6), 1182–1192.
20. McDonald, S. D., Vermeulen, M. J., & Ray, J. G. (2007). Risk of fetal death associated with maternal drug dependence and placental abruption: A population-based study. Journal of Obstetrics and Gynaecology of Canada, 29(7), 556–559.
21. Miller-Loncar, C., Lester, B. M., Seifer, R., Lagasse, L. L., Bauer, C. R., et al. (2005). Predictors of motor development in children prenatally exposed to cocaine. Neurotoxicology and Teratology, 27(2), 213–220.
22. Ness, R. B., Grisso, J. A., Hirschinger, N., et al. (1999). Cocaine and tobacco use and the risk of spontaneous abortion. New England Journal of Medicine, 340(5), 333–339.
23. Office of Applied Studies. (2007a). Substance abuse and mental health services administration. The NSDUH report: Substance use treatment among women of childbearing age. Rockville: National Clearinghouse for Alcohol and Drug Information.
24. Office of Applied Studies. (2007b) Substance abuse and mental health services administration (SAMHSA). Results from the 2006 national survey on drug use and health: National findings. Rockville: National Clearinghouse for Alcohol and Drug Information.
25. Office of Applied Studies. (2008) Substance abuse and mental health services administration (SAMHSA). Results from the 2007 national survey on drug use and health: National findings. Rockville: National Clearinghouse for Alcohol and Drug Information.
26. Ornoy, A., Segal, J., Bar-Hamburger, R., Greenbaum C. (2001). Developmental outcome of school-age children born to mothers with heroin dependency: Importance of environmental factors. Developmental Medicine and Child Neurolology, 43(10), 668–675.
27. Pan, I. J., & Yi, H. Y. (2013). Prevalence of hospitalized births affected by alcohol and drug and parturient women diagnosed with substance abuse at live birth delivery: United States, 1999–2008. Maternal and Child Health Journal 17, 667–676.
28. Parlier, A. B., Fagan, B., Ramage, M., Galvin, S. (2014). Prenatal care, pregnancy outcomes, and postpartum birth control plans among pregnant women with opiate addictions. Southern Medical Journal, 107, 676–683.
29. Roberts, S. C. M., & Pies, C. (2011). Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care. Maternal and Child Health Journal, 15, 333–341.
30. Shankaran, S., Das, A., Bauer, C. R., Bada, H. S., Lester, B., et al. (2004). Association between patterns of maternal substance use and infant birth weight, length, and head circumference. Pediatrics, 114(2), e226–e234.
31. Tuthill, D. P. (2000). Tobacco and cocaine use were independent risk factors for spontaneous abortion in inner-city women. Evidence-based Obstetrics and Gynecology, 2(1), 14.
32. Wright, A., Walker, J. (2001). Drugs of abuse in pregnancy. Best Practice and Research in Clinical Obstetrics and Gynaecology, 15(6), 987–998.